More Mentions

February 15, 2017 Regulatory Affairs Professionals Society, AbbVie, Novartis Criticize FDA’s Guidance on Nonproprietary Names for Biologics and Biosimilars, Zachary Brennan

Related Content

September 4, 2018 S&P Global Market Intelligence: Drugmakers, Public Weigh In On Efforts to Boost US Biosimilar Competition

June 21, 2018 Healio, Concerns over nonmedical switching of biologics spur physician guidelines

June 21, 2018 The Center for Biosimilars, BPC’s Nonmedical Switching Guidelines Seek to Preserve Physician–Patient Relationship

Stay Informed View the latest newsletter

To receive regular newsletters and periodic alerts from the BPC, enter your email address in the form below:

(function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]='EMAIL';ftypes[0]='email';fnames[1]='FNAME';ftypes[1]='text';fnames[2]='LNAME';ftypes[2]='text';}(jQuery));var $mcj = jQuery.noConflict(true);